The Locator -- [(subject = "Pharmaceutical policy--United States")]

111 records matched your query       


Record 13 | Previous Record | MARC Display | Next Record | Search Results
Author:
Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development (2011 : Washington, D.C.)
Title:
Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development : workshop summary / Steve Olson and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies.
Publisher:
National Academies Press,
Copyright Date:
c2012
Description:
xvi, 102 p. : ill. ; 23 cm.
Subject:
United States.--Food and Drug Administration.
Pharmaceutical policy--United States--Regulations--Congresses.
Drugs--United States--Regulations--Congresses.
Drug development--United States--Congresses.
Pharmaceutical industry--Vocational guidance--United States--Congresses.
Pharmaceutical industry--United States--Quality control--Congresses.
Other Authors:
Olson, Steve, 1956-
Claiborne, Anne B.
Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation.
Notes:
Includes bibliographical references (p. 65).
Contents:
Introduction -- Defining a discipline of regulatory science and core competencies for its workforce -- Education and training of a regulatory science workforce -- Career paths within academia and industry -- International applications of regulatory science -- Collaborative models and new paradigms for supporting regulatory science research and practice.
Summary:
The development and application of regulatory science - which FDA has defined as the science of developing new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of FDA-regulated products - calls for a well-trained, scientifically engaged, and motivated workforce. FDA faces challenges in retaining regulatory scientists and providing them with opportunities for professional development. In the private sector, advancement of innovative regulatory science in drug development has not always been clearly defined, well coordinated, or connected to the needs of the agency. As a follow-up to a 2010 workshop, the IOM held a workshop on September 20-21, 2011, to provide a format for establishing a specific agenda to implement the vision and principles relating to a regulatory science workforce and disciplinary infrastructure as discussed in the 2010 workshop-- Source other than Library of Congress.
ISBN:
0309222141
9780309222143
OCLC:
(OCoLC)773671733
LCCN:
2012405371
Locations:
USUX851 -- Iowa State University - Parks Library (Ames)
OVUX522 -- University of Iowa Libraries (Iowa City)

Initiate Another SILO Locator Search

This resource is supported by the Institute of Museum and Library Services under the provisions of the Library Services and Technology Act as administered by State Library of Iowa.